Drugs / Contractubex
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT03777891 | Jun 2017 | reactive cutaneous fibrous lesion | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT01112371 | Feb 2011 → Feb 2012 | — | Merz Pharmaceuticals GmbH | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01861119 Comparator | Apr 2013 → Feb 2014 | reactive cutaneous fibrous lesion | CHA University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Contractubex | “Group B (GB) received Contractubex phonophoresis: Contractubex (Merz Pharma, Frankfurt, Germany was applied to the scar” NCT03777891 ↗ |
| Known as | Onion extract gel | “Onion extract gel (Contractubex™; Merz Pharma, Frankfurt, Germany) From the day of suture removal, the treatment was applied three times daily for 3 months.” NCT01861119 ↗ |
| Route | Topical | “A topical scar gel containing extract of Allium cepae, allantoin and heparin (Contractubex®; Merz Pharmaceuticals GmbH, Germany)” PMID 24509969 ↗ Feb 2014 |